Nanoparticles are revolutionizing the delivery of pharmaceutical drugs by providing creative answers to some of the most significant problems with conventional treatments, including inadequate bioavailability, poor water solubility, and lack of tailored delivery.These microscopic carriers contribute to increased therapeutic efficacy and decreased undesirable side effects by permitting controlled and site-specific medication release.For drug delivery, a large range of nanoparticle types have been investigated, including dendrimers, metallic particles, polymeric nanoparticles, lipid-based systems, and carbon-based nanostructures.Treatments for diseases including cancer, neurological disorders, and infectious diseases have already showed promise due to their special capacity to penetrate biological barriers and interact with particular cells in a targeted manner.The classification, manufacturing, and functionality of these nanoparticles when they are loaded with medicinal compounds are all examined in further detail in this paper.It also discusses significant safety and regulatory issues, as well as their present medical use, including formulations that have FDA approval.Lastly, it examines fascinating new discoveries that are advancing our understanding of genuinely customized treatment alternatives, such as multifunctional nanoparticles and the application of artificial intelligence in the creation of next-generation nanomedicines.
No takes yet. Share an insight, caveat, or question.
Baokar et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: